EcoDrugPlus

Ensembl ID : ENSPMAG00000000916
Gene Symbol: -
Cross references: -
256 Possible Orthologues:

Ensembl ID : ENSPMAG00000000933
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSPMAG00000000962
Gene Symbol: -
Cross references: -
282 Possible Orthologues:

Ensembl ID : ENSPMAG00000001045
Gene Symbol: -
Cross references: -
204 Possible Orthologues:

Ensembl ID : ENSPMAG00000001055
Gene Symbol: -
Cross references: -
217 Possible Orthologues:

Ensembl ID : ENSPMAG00000001078
Gene Symbol: -
Cross references: -
971 Possible Orthologues:

Ensembl ID : ENSPMAG00000001392
Gene Symbol: -
Cross references: -
248 Possible Orthologues:

Ensembl ID : ENSPMAG00000001493
Gene Symbol: -
Cross references: -
196 Possible Orthologues:

Ensembl ID : ENSPMAG00000001495
Gene Symbol: -
Cross references: -
282 Possible Orthologues:

Ensembl ID : ENSPMAG00000001500
Gene Symbol: -
Cross references: -
219 Possible Orthologues:

Ensembl ID : ENSPMAG00000002047
Gene Symbol: PSENEN
1 Cross references
183 Possible Orthologues:

Ensembl ID : ENSPMAG00000002153
Gene Symbol: RPL34
1 Cross references
368 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).